GNPX MEXC RealStocks
Own real GNPX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 03:36:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Genprex, Inc. (GNPX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.24, with a market capitalization of $1.71M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.71 to $110.00. This page covers its latest market performance, valuation, price trends and company information.
$1.71M | |
$2.30 | |
$2.38 | |
$2.22 | |
$2.29 | |
18.20K | |
248.15K | |
-- | |
$110.00 | |
$1.71 | |
-- | |
-- |
Genprex, Inc. (GNPX) last closed at $2.24 as of 2026-11-13 00:31:00, down 2.61% ($0.06) from the previous close of $2.29.
During the latest regular trading session, GNPX traded between $2.22 and $2.39, with a volume of 18.20K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Genprex, Inc. (GNPX) moved from $2.31 to $2.24, representing a decline of 3.03% ($0.07).
The stock traded between $1.95 and $2.39 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.
The average daily volume was 160.97 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.5%
GNPX is currently trading at $2.24, placing it 0.5% of the way from its 52-week low of $1.71 to its 52-week high of $110.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 13 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Genprex, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Genprex, Inc. (GNPX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to GNPX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between GNPX shares and USD.
GNPX Shares to USD
1.00 GNPX shares = 2.24 USD
Calculations are estimates based on the latest available price and are for reference only.